Vitrolife: Expectations ahead of Q4 - Redeye

Vitrolife will release the Q4 results on 2 February. As a result of the earlier trading update, the main interest is in the outlook, especially for the US-related Genetic Services business. Our Base Case ahead of Q4 is SEK 235 (Bull SEK 375 and Bear SEK 85).

Länk till analysen i sin helhet: https://www.redeye.se/research/973135/vitrolife-expectations-ahead-of-q4?utm_source=finwire&utm_medium=RSS